Change in Myasthenia Gravis Epidemiology in Trento, Italy, after Twenty Years

被引:36
作者
Pallaver, Fabrizio
Riviera, Anna Pia [5 ]
Piffer, Silvano [2 ]
Ricciardi, Roberta [4 ]
Roni, Riccardo [3 ]
Orrico, Daniele
Bonifati, Domenico Marco [1 ]
机构
[1] Santa Chiara Hosp, Neurol Unit, Dept Neurol Disorders, IT-38100 Trento, Italy
[2] Azienda Prov Serv Sanit, Epidemiol Serv, Trento, Italy
[3] Azienda Prov Serv Sanit, Pharmaceut Serv, Trento, Italy
[4] Univ Pisa, Dept Neurosci, Pisa, Italy
[5] Univ Verona, Dept Immunol, I-37100 Verona, Italy
关键词
Myasthenia gravis incidence; Trento; Italy;
D O I
10.1159/000328863
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The recent literature suggests that the incidence and prevalence of myasthenia gravis (MG) are changing. We performed a population-based study of MG in the province of Trentino (524,826 inhabitants) and compared the results with those collected 20 years ago. Methods: Multiple sources of information (discharge diagnosis, antibody tests and anticholinesterase drugs) were analyzed. Incidence was calculated from 2005 to 2009. Prevalence was calculated on December 31, 2009. Comparison was made with descriptive statistics for 1981-1990 for the identical region. Results: Incidence and prevalence greatly increased in comparison with 1981-1990 data. The prevalence rate increased from 82.9 (95% confidence interval, Cl, 58.4-114.3) in 1990 to 129.6 (95% CI 100.6-164.3) per million population, whereas the average annual incidence increased from 7.4 (95% CI 5-10.4) per million person-years in 1981-1990 to 14.8 (95% CI 10.5-20.3) in 2005-2009. This increase was mainly due to male patients with late-onset MG. Conclusions: The study confirms the increase in incidence and prevalence of late-onset MG in the same region 20 years apart. So we should consider MG also as a disease of the elderly. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:282 / 287
页数:6
相关论文
共 20 条
[1]   Myasthenia gravis -: A higher than expected incidence in the elderly [J].
Aragonès, JM ;
Bolíbar, L ;
Bonfill, X ;
Bufill, E ;
Mummany, A ;
Alonso, F ;
Illa, I .
NEUROLOGY, 2003, 60 (06) :1024-1026
[2]   A systematic review of population based epidemiological studies in Myasthenia Gravis [J].
Carr, Aisling S. ;
Cardwell, Chris R. ;
McCarron, Peter O. ;
McConville, John .
BMC NEUROLOGY, 2010, 10
[3]   Myasthenia gravis: a changing pattern of incidence [J].
Casetta, I. ;
Groppo, E. ;
De Gennaro, R. ;
Cesnik, E. ;
Piccolo, L. ;
Volpato, S. ;
Granieri, E. .
JOURNAL OF NEUROLOGY, 2010, 257 (12) :2015-2019
[4]   Epidemiology of autoimmune diseases in Denmark [J].
Eaton, William W. ;
Rose, Noel R. ;
Kalaydjian, Amanda ;
Pedersen, Marianne G. ;
Mortensen, Preben Bo .
JOURNAL OF AUTOIMMUNITY, 2007, 29 (01) :1-9
[5]   MYASTHENIA GRAVIS - A PERSONAL STUDY OF 60 CASES [J].
GARLAND, H ;
CLARK, ANG .
BMJ-BRITISH MEDICAL JOURNAL, 1956, 1 (JUN2) :1259-1262
[6]   THE NATURAL COURSE OF MYASTHENIA-GRAVIS AND EFFECT OF THERAPEUTIC MEASURES [J].
GROB, D ;
BRUNNER, NG ;
NAMBA, T .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1981, 377 (DEC) :652-669
[7]   Lifetime course of myasthenia gravis [J].
Grob, David ;
Brunner, Norman ;
Namba, Tatsuji ;
Pagala, Murali .
MUSCLE & NERVE, 2008, 37 (02) :141-149
[8]   SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY [J].
Heldal, Anne Taraldsen ;
Owe, Jone Furlund ;
Gilhus, Nils Erik ;
Romi, Fredrik .
NEUROLOGY, 2009, 73 (02) :150-151
[9]  
LOVASTE MG, 1992, NEUROEPIDEMIOLOGY, V11, P135
[10]   Myasthenia gravis (MG): Epidemiological data and prognostic factors [J].
Mantegazza, R ;
Baggi, F ;
Antozzi, C ;
Confalonieri, P ;
Morandi, L ;
Bernasconi, P ;
Andreetta, F ;
Simoncini, O ;
Campanella, A ;
Beghi, E ;
Cornelio, F .
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :413-423